SCHEMBL21045970

SCHEMBL21045970

CC(C)(C)OC(=O)N1CC(C2CCNCC2)=CC=C1N

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PLAT P00750 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
KDM1A O60341 2/20 0.34
MAPK1 P28482 1/20 0.34
NR1H2 P55055 1/20 0.34
CHRM2 P08172 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
GPR119 Q8TDV5 4/20 0.32
SCN9A Q15858 1/20 0.32
SCN3A Q9NY46 1/20 0.32
SCN5A Q14524 1/20 0.32
NAMPT P43490 1/20 0.32
PTPN2 P17706 1/20 0.32
PTPN1 P18031 1/20 0.32
PTPN6 P29350 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15059576 0.82 GPR119 (0.34) PLATKDM4EMAPTTHRBKDM1A
SCHEMBL4242555 0.80 PLAT (0.35) PLATKDM4EMAPTTHRBKDM1A
SCHEMBL21274226 0.78 PLAT (0.33) PLATKDM4EMAPTTHRBKDM1A
SCHEMBL17241212 0.75 GPR119 (0.37) PLATKDM4EMAPTTHRBKDM1A
SCHEMBL3073012 0.74 PLAT (0.35) PLATKDM4EMAPTTHRBMAPK1
SCHEMBL7309434 0.72 NR1H2 (0.38) KDM1AMAPK1NR1H2GPR119NAMPT
SCHEMBL8701590 0.70 PLAT (0.35) PLATKDM4EMAPTTHRBKDM1A
SCHEMBL4236593 0.70 PLAT (0.34) PLATKDM4EMAPTTHRBCHRM2
SCHEMBL7307321 0.70 NR1H2 (0.41) KDM4EMAPTTHRBKDM1AMAPK1
SCHEMBL2811591 0.68 PLAT (0.37) PLATKDM4EMAPTTHRBKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11485740-B2 Inhibitors of TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-11-01 US disclosed
US-20200399282-A1 INHIBITORS OF TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2020-12-24 US disclosed
EP-3752499-A1 INHIBITORS OF TRPC6 Boehringer Ingelheim International GmbH (DE) 2020-12-23 EP disclosed
WO-2019158572-A1 INHIBITORS OF TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-08-22 WO disclosed
US-20190169167-A1 INHIBITORS OF TRPC6 BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2019-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200399282-A1 INHIBITORS OF TRPC6 TRPC6, TRPC1, TRPC4 PLAT 4536/4885KDM4E 3485/4885MAPT 1780/4885
US-11485740-B2 Inhibitors of TRPC6 TRPC6, TRPC1, TRPC4 PLAT 4536/4885KDM4E 3485/4885MAPT 1780/4885
US-20190169167-A1 INHIBITORS OF TRPC6 TRPC6, TRPC1, TRPC7 PLAT 4767/4885KDM4E 3581/4885MAPT 2284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.